Article
Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus.
Journal of medicinal chemistry - 14 Oct 2010
Sofia Michael J, Bao Donghui, Chang Wonsuk, Du Jinfa, Nagarathnam Dhanapalan, Rachakonda Suguna, Reddy P Ganapati, Ross Bruce S, Wang Peiyuan, Zhang Hai-Ren, Bansal Shalini, Espiritu Christine, Keilman Meg, Lam Angela M, Steuer Holly M Micolochick, Niu Congrong, Otto Michael J, Furman Phillip A
Abstract excerpt
Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease. The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies. β-d-2'-Deoxy-2'-α-fluoro-2'-β-C-methyl nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic. Phosphoramidate prodrugs of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
